Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Stockert

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Cancer Immunity|May 16, 2003
Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expressionM J Scanlan, I Gout, C M Gordon, et al.
Cancer Research|June 19, 2001
Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor gradeT Kurashige, Y Noguchi, T Saika, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTLJ L Chen, P R Dunbar, U Gileadi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanomaD Rimoldi, V Rubio-Godoy, V Dutoit, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2000
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancersE Jäger, S Gnjatic, Y Nagata, et al.
International Journal of Cancer|October 3, 1999
Antigens recognized by autologous antibody in patients with renal-cell carcinomaM J Scanlan, J D Gordan, B Williamson, et al.
Cancer Research|July 17, 2001
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptorK Mishima, T G Johns, R B Luwor, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I alleleS Gnjatic, Y Nagata, E Jager, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2000
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responsesE Jäger, Y Nagata, S Gnjatic, et al.
Cancer Research|June 24, 2000
Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumorsA M Scott, D Geleick, M Rubira, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Cancer Immunity|May 16, 2003
Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expressionM J Scanlan, I Gout, C M Gordon, et al.
Cancer Research|June 19, 2001
Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor gradeT Kurashige, Y Noguchi, T Saika, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTLJ L Chen, P R Dunbar, U Gileadi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanomaD Rimoldi, V Rubio-Godoy, V Dutoit, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2000
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancersE Jäger, S Gnjatic, Y Nagata, et al.
International Journal of Cancer|October 3, 1999
Antigens recognized by autologous antibody in patients with renal-cell carcinomaM J Scanlan, J D Gordan, B Williamson, et al.
Cancer Research|July 17, 2001
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptorK Mishima, T G Johns, R B Luwor, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I alleleS Gnjatic, Y Nagata, E Jager, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2000
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responsesE Jäger, Y Nagata, S Gnjatic, et al.
Cancer Research|June 24, 2000
Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumorsA M Scott, D Geleick, M Rubira, et al.
Pageof 10